ABIN1 dysfunction as a genetic basis for lupus nephritis

Journal of the American Society of Nephrology

Volumn 24, Issue 11, 2013, Pages 1743-1754

  Caster, Dawn J ^a   Korte, Erik A ^a   Nanda, Sambit K ^c   McLeish, Kenneth R ^a,b   Oliver, Rebecca K ^a   G'Sell, Rachel T ^a   Sheehan, Ryan M ^a   Freeman, Darrell W ^a   Coventry, Susan C ^a   Kelly, Jennifer A ^d   Guthridge, Joel M ^d   James, Judith A ^d   Sivils, Kathy L ^d   Alarcon Riquelme, Marta E ^d   Scofield, R Hal ^d   Adrianto, Indra ^d   Gaffney, Patrick M ^d   Stevens, Anne M ^e   Freedman, Barry I ^f   Langefeld, Carl D ^f   Tsao, Betty P ^g   Pons Estel, Bernardo A ^h   Jacob, Chaim O ⁱ   Kamen, Diane L ^j   Gilkeson, Gary S ^j   Brown, Elizabeth E ^k   Alarcon, Graciela S ^k   Edberg, Jeffrey C ^k   Kimberly, Robert P ^k   Martin, Javier ^l   Merrill, Joan T ^d   Harley, John B ^m   Kaufman, Kenneth M ⁿ   Reveille, John D ⁿ   Anaya, Juan Manuel ^o   Criswell, Lindsey A ^p   Vila, Luis M ^q   Petri, Michelle ^r   Ramsey Goldman, Rosalind ^s   Bae, Sang Cheol ^t   Boackle, Susan A ^u   Vyse, Timothy J ^v   Niewold, Timothy B ^w   Cohen, Philip ^c   Powell, David W ^a   more..

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Sanatorio Parque   (Argentina)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^l INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^m CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o UNIVERSIDAD DEL ROSARIO   (Colombia)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^r JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s NORTHWESTERN UNIVERSITY   (United States)

^t Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^u UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^v KING'S COLLEGE LONDON   (United Kingdom)

^w MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR;

A20 BINDING INHIBITOR OF IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1 GENE; AFRICAN AMERICAN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE; GENOTYPE; IMMUNOCOMPETENT CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84887052296     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013020148     Document Type: Article

References (62)

1. Tsokos GC: Systemic lupus erythematosus. N Engl J Med 365: 2110-2121, 2011
2. Weening JJ, D'Agati VD, Schwartz MM, Seshan S.V., Alpers CE, Appel GB, Balow JE, Bruijn J.A., Cook T., Ferrario F, Fogo AB, Ginzler E.M., Hebert L., Hill G, Hill P, Jennette J.C., Kong NC, Lesavre P, Lockshin M, Looi L.M., Makino H., Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004 (Pubitemid 38140764)
3. Borchers AT, Leibushor N, Naguwa SM, Cheema G.S., Shoenfeld Y, Gershwin ME: Lupus nephritis: A critical review. Autoimmun Rev 12: 174-194, 2012
4. Buhaescu I, Covic A, Deray G: Treatment of proliferative lupus nephritis - a critical approach. Semin Arthritis Rheum 36: 224-237, 2007 (Pubitemid 46178520)
5. Kalergis AM, Iruretagoyena MI, Barrientos M.J., González PA, Herrada A.A., Leiva ED, Gutiérrez MA, Riedel C.A., Bueno SM, Jacobelli SH: Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology 128[Suppl]: e306-e314, 2009
6. Kang HK, Ecklund D, Liu M., Datta SK: Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arthritis Res Ther 11: R59, 2009
7. Zheng L, Sinniah R, Hsu SI: Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol 37: 637-647, 2006 (Pubitemid 43956530)
8. Zheng L, Sinniah R, Hsu SI: In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch 448: 172-183, 2006 (Pubitemid 43237883)
9. Zheng L, Sinniah R, Hsu SI: Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis. J Histochem Cytochem 56: 517-529, 2008 (Pubitemid 351556494)
10. Oeckinghaus A, Hayden MS, Ghosh S: Crosstalk in NF-κB signaling pathways. Nat Immunol 12: 695-708, 2011
11. Verma IM, Stevenson JK, Schwarz E.M., Van Antwerp D, Miyamoto S: Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev 9: 2723-2735, 1995 (Pubitemid 3009952)
12. Jacobs MD, Harrison SC: Structure of an IkappaBalpha/NF-kappaB complex. Cell 95: 749-758, 1998
13. Karin M: How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene 18: 6867-6874, 1999
14. Adhikari A, Xu M, Chen ZJ: Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226, 2007 (Pubitemid 46763016)
15. Tokunaga F, Sakata S, Saeki Y., Satomi Y, Kirisako T, Kamei K., Nakagawa T, Kato M, Murata S, Yamaoka S, Yamamoto M., Akira S, Takao T, Tanaka K., Iwai K: Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11: 123-132, 2009
16. Rahighi S, Ikeda F, Kawasaki M., Akutsu M, Suzuki N, Kato R., Kensche T, Uejima T, Bloor S., Komander D, Randow F, Wakatsuki S., Dikic I: Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: 1098-1109, 2009
17. Haas TL, Emmerich CH, Gerlach B, Schmukle A.C., Cordier SM, Rieser E, Feltham R, Vince J., Warnken U, Wenger T, Koschny R., Komander D, Silke J, Walczak H: Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36: 831-844, 2009
18. Vereecke L, Beyaert R, van Loo G: The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol 30: 383-391, 2009
19. Verstrepen L, Carpentier I, Verhelst K., Beyaert R: ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochem Pharmacol 78: 105-114, 2009
20. Conze DB, Wu CJ, Thomas J.A., Landstrom A., Ashwell JD: Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation. Mol Cell Biol 28: 3538-3547, 2008 (Pubitemid 351657114)
21. Laplantine E, Fontan E, Chiaravalli J., Lopez T, Lakisic G, Véron M, Agou F., Israël A: NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J 28: 2885-2895, 2009
22. Windheim M, Stafford M, Peggie M., Cohen P: Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. Mol Cell Biol 28: 1783-1791, 2008
23. Mauro C, Pacifico F, Lavorgna A., Mellone S, Iannetti A, Acquaviva R., Formisano S, Vito P, Leonardi A: ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J Biol Chem 281: 18482-18488, 2006 (Pubitemid 44035507)
24. Evans PC, Ovaa H, Hamon M., Kilshaw PJ, Hamm S, Bauer S, Ploegh H.L., Smith TS: Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 378: 727-734, 2004 (Pubitemid 38406847)
25. Shembade N, Ma A, Harhaj EW: Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327: 1135-1139, 2010
26. Nanda SK, Venigalla RK, Ordureau A, Patterson-Kane JC, Powell D.W., Toth R., Arthur JS, Cohen P: Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 208: 1215-1228, 2011
27. Moon MR, Parikh AA, Pritts T.A., Fischer JE, Cottongim S, Szabo C, Salzman A.L., Hasselgren PO: Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32β6 mutant IkappaBalpha. J Surg Res 82: 48-55, 1999 (Pubitemid 29394152)
28. Oeckinghaus A, Ghosh S: TheNF-kappaB family oftranscription factors and its regulation. Cold Spring Harb Perspect Biol 1: a000034, 2009
29. Castellano G, Cappiello V, Fiore N., Pontrelli P, Gesualdo L, Schena F.P., Montinaro V: CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells. J Am Soc Nephrol 16: 2003-2011, 2005 (Pubitemid 41716431)
30. Adrianto I, Wang S, Wiley G.B., Lessard CJ, Kelly JA, Adler AJ, Glenn S.B., Williams AH, Ziegler JT, Comeau ME, Marion M.C., Wakeland BE, Liang C, Kaufman KM, Guthridge J.M., Alarcón-Riquelme ME; BIOLUPUS and GENLES Networks, Alarcón GS, Anaya JM, Bae SC, Kim JH, Joo YB, Boackle SA, Brown EE, Petri MA, Ramsey-Goldman R, Reveille JD, Vilá LM, Criswell LA, Edberg JC, Freedman BI, Gilkeson GS, Jacob CO, James JA, Kamen DL, Kimberly RP, Martín J, Merrill JT, Niewold TB, Pons-Estel BA, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Harley JB, Wakeland EK, Moser KL, Montgomery CG, Gaffney PM. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum 64: 3695-3705, 2012
31. Gateva V, Sandling JK, Hom G, Taylor K.E., Chung SA, Sun X, Ortmann W, Kosoy R., Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E., Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Rantapää-Dahlqvist S, Baechler EC, Brown EE, Alarcón GS, Edberg JC, Ramsey-Goldman R, McGwin G Jr, Reveille JD, Vilá LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, Seldin MF, Rönnblom L, Criswell LA, Syvänen AC, Behrens TW, Graham RR: A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233, 2009
32. Allanore Y, Saad M, Dieudé P, Avouac J, Distler JH, Amouyel P, Matucci-Cerinic M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Wipff J, Lambert JC, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal-Bielecka O, Valentini G, Mouthon L, Czirják L, Damjanov N, Salvi E, Conti C, Müller M, Müller-Ladner U, Riccieri V, Ruiz B, Cracowski JL, Letenneur L, Dupuy AM, Meyer O, Kahan A, Munnich A, Boileau C, Martinez M: Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 7: e1002091, 2011
33. Wu CJ, Conze DB, Li T, Srinivasula S.M., Ashwell JD: Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8: 398-406, 2006
34. Ea CK, Deng L, Xia Z.P., Pineda G., Chen ZJ: Activation of IKK by TNFαlpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22: 245-257, 2006
35. Ikeda F, Deribe YL, Skånland SS, Stieglitz B., Grabbe C, Franz-Wachtel M, van Wijk SJ, Goswami P, Nagy V, Terzic J., Tokunaga F, Androulidaki A, Nakagawa T., Pasparakis M, Iwai K, Sundberg JP, Schaefer L, Rittinger K, Macek B., Dikic I: SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471: 637-641, 2011
36. Wagner S, Carpentier I, Rogov V., Kreike M, Ikeda F, Löhr F, Wu C.J., Ashwell JD, Dötsch V, Dikic I., Beyaert R: Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745, 2008 (Pubitemid 351912974)
37. Oshima S, Turer EE, Callahan J.A., Chai S., Advincula R, Barrera J, Shifrin N., Lee B, Benedict Yen TS, Woo T, Malynn BA, Ma A: ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457: 906-909, 2009
38. Heyninck K, Kreike MM, Beyaert R: Structure-function analysis of the A20-bindinginhibitor of NF-kappa B activation, ABIN-1. FEBS Lett 536: 135-140, 2003 (Pubitemid 36206420)
39. Zhou J, Wu R, High A.A., Slaughter CA, Finkelstein D, Rehg JE, Redecke V, Häcker H: A20-binding inhibitor of NF-κB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein b activation and protects from inflammatory disease. Proc Natl Acad Sci U S A 108: E998-E1006, 2011
40. Stambe C, Atkins RC, Tesch G.H., Kapoun AM, Hill PA, Schreiner GF, Nikolic-Paterson DJ: Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 14: 338-351, 2003 (Pubitemid 36150857)
41. Stambe C, Nikolic-Paterson DJ, Hill P.A., Dowling J., Atkins RC: p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: Correlation with renal injury. J Am Soc Nephrol 15: 326-336, 2004 (Pubitemid 38140773)
42. Koshikawa M, Mukoyama M, Mori K., Suganami T, Sawai K, Yoshioka T., Nagae T, Yokoi H, Kawachi H., Shimizu F, Sugawara A, Nakao K: Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16: 2690-2701, 2005
43. Sheryanna A, Bhangal G, McDaid J., Smith J, Manning A, Foxwell B.M., Feldmann M., Cook HT, Pusey CD, Tam FW: Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol 18: 1167-1179, 2007 (Pubitemid 46536903)
44. Ikezumi Y, Hurst L, Atkins R.C., Nikolic-Paterson DJ: Macrophage-mediatedrenal injury is dependenton signaling via the JNK pathway. J Am Soc Nephrol 15: 1775-1784, 2004 (Pubitemid 38822056)
45. Han JW, Zheng HF, Cui Y, Sun L.D., Ye DQ, Hu Z, Xu JH, Cai Z.M., Huang W., Zhao GP, Xie HF, Fang H, Lu Q.J., Xu JH, Li XP, Pan YF, Deng D.Q., Zeng FQ, Ye ZZ, Zhang XY, Wang Q.W., Hao F., Ma L, Zuo XB, Zhou F.S., Du WH, Cheng YL, Yang JQ, Shen S.K., Li J., Sheng YJ, Zuo XX, Zhu WF, Gao F, Zhang P.L., Guo Q., Li B, Gao M, Xiao F.L., Quan C., Zhang C, Zhang Z, Zhu K.J., Li Y., Hu DY, Lu WS, Huang JL, Liu S.X., Li H., Ren YQ, Wang ZX, Yang CJ, Wang PG, Zhou WM, Lv YM, Zhang AP, Zhang SQ, Lin D, Li Y, Low HQ, Shen M, Zhai ZF, Wang Y, Zhang FY, Yang S, Liu JJ, Zhang XJ: Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41: 1234-1237, 2009
46. Kawasaki A, Ito S, Furukawa H., Hayashi T, Goto D, Matsumoto I., Kusaoi M, Ohashi J, Graham R.R., Matsuta K., Behrens TW, Tohma S, Takasaki Y, Hashimoto H., Sumida T, Tsuchiya N: Association of TNFAIP3 interacting protein 1, TNIP1 with systemic lupus erythematosus in a Japanese population: A case-control association study. Arthritis Res Ther 12: R174, 2010
47. He CF, Liu YS, Cheng Y.L., Gao JP, Pan TM, Han JW, Quan C, Sun L.D., Zheng HF, Zuo XB, Xu SX, Sheng Y.J., Yao S., Hu WL, Li Y, Yu ZY, Yin X.Y., Zhang XJ, Cui Y, Yang S: TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19: 1181-1186, 2010
48. Zhong H, Li XL, Li M, Hao L.X., Chen RW, Xiang K, Qi XB, Ma R.Z., Su B: Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 13: R186, 2011
49. Weening JJ, D'Agati VD, Schwartz MM, Seshan S.V., Alpers CE, Appel GB, Balow JE, Bruijn J.A., Cook T., Ferrario F, Fogo AB, Ginzler E.M., Hebert L., Hill G, Hill P, Jennette J.C., Kong NC, Lesavre P, Lockshin M, Looi L.M., Makino H., Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Neph-ritis Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521-530, 2004 (Pubitemid 38130646)
50. Kurien BT, Scofield RH: Mouse urine collection using clear plastic wrap. Lab Anim 33: 83-86, 1999 (Pubitemid 29050724)
51. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997
52. Nair RP, Duffin KC, Helms C, Ding J., Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T., Feng BJ, Ruether A, Schreiber S, Weichenthal M., Gladman D, Rahman P, Schrodi S.J., Prahalad S., Guthery SL, Fischer J, Liao W, Kwok P.Y., Menter A., Lathrop GM, Wise CA, Begovich AB, Voorhees J.J., Elder JT, Krueger GG, Bowcock AM, Abecasis GR; Collaborative Association Study of Psoriasis: Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: 199-204, 2009
53. Sun LD, Cheng H, Wang Z.X., Zhang AP, Wang PG, Xu JH, Zhu Q.X., Zhou HS, Ellinghaus E, Zhang FR, Pu XM, Yang XQ, Zhang JZ, Xu AE, Wu RN, Xu LM, Peng L, Helms CA, Ren YQ, Zhang C, Zhang SM, Nair RP, Wang HY, Lin GS, Stuart PE, Fan X, Chen G, Tejasvi T, Li P, Zhu J, Li ZM, Ge H M, Weichenthal M, Ye WZ, Zhang C, Shen SK, Yang BQ, Sun YY, Li SS, Lin Y, Jiang JH, Li CT, Chen RX, Cheng J, Jiang X, Zhang P, Song WM, Tang J, Zhang HQ, Sun L, Cui J, Zhang LJ, Tang B, Huang F, Qin Q, Pei XP, Zhou AM, Shao LM, Liu JL, Zhang FY, Du WD, Franke A, Bowcock AM, Elder JT, Liu JJ, Yang S, Zhang XJ: Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet 42: 1005-1009, 2010
54. Bowes J, Orozco G, Flynn E., Ho P, Brier R, Marzo-Ortega H, Coates L., McManus R, Ryan AW, Kane D, Korendowych E., McHugh N, FitzGerald O, Packham J., Morgan AW, Bruce IN, Barton A: Confirmation of TNIP1 and IL23Aas susceptibility loci for psoriatic arthritis. Ann Rheum Dis 70: 1641-1644, 2011
55. Hoggart CJ, Parra EJ, Shriver M.D., Bonilla C., Kittles RA, Clayton DG, McKeigue PM: Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72: 1492-1504, 2003 (Pubitemid 36628388)
56. Hoggart CJ, Shriver MD, Kittles R.A., Clayton DG, McKeigue PM: Design and analysis of admixture mapping studies. Am J Hum Genet 74: 965-978, 2004 (Pubitemid 38568969)
57. Price AL, Patterson NJ, Plenge R.M., Weinblatt M E, ShadickN A, Reich D: Principal components analysis corrects for stratification in genomewide association studies. Nat Genet 38: 904-909, 2006 (Pubitemid 44141658)
58. Lessard CJ, Adrianto I, Kelly J.A., Kaufman KM, Grundahl KM, Adler A, Williams A.H., Gallant CJ, Anaya JM, Bae SC, Boackle S.A., Brown EE, Chang DM, Criswell LA, Edberg J.C., Freedman BI, Gregersen PK, Gilkeson GS, Jacob C.O., James JA, Kamen DL, Kimberly RP, Martin J, Merrill J.T., Niewold TB, Park SY, Petri MA, Pons-Estel BA, Ramsey-Goldman R, Reveille J.D., Song YW, Stevens AM, Tsao BP, Vila L.M., Vyse TJ, Yu CY, Guthridge JM, Bruner G.R., Langefeld CD, Montgomery C, Harley JB, Scofield R.H., Gaffney PM, Moser KL; Marta E. Alarcón-Riquelmeon behalf of the BIOLUPUS and GENLES Networks: Identification of a systemic lupus erythematosus susceptibility locus at 11 p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet 88: 83-91, 2011
59. Adrianto I, Wen F, Templeton A., Wiley G, King JB, Lessard C.J., Bates JS, Hu Y, Kelly JA, Kaufman K.M., Guthridge JM, Alarcón-Riquelme ME, Anaya JM, Bae SC, Bang SY, Boackle SA, Brown EE, Petri MA, Gallant C, Ramsey-Goldman R, Reveille JD, Vila LM, Criswell LA, Edberg JC, Freedman BI, Gregersen PK, Gilkeson GS, Jacob CO, James JA, Kamen DL, Kimberly RP, Martin J, Merrill JT, Niewold TB, Park SY, Pons-Estel BA, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Harley JB, Moser KL, Webb CF, Humphrey MB, Montgomery CG, Gaffney PM; BIOLUPUS and GENLES Networks: Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 43: 253-258, 2011
60. Purcell S, Neale B, Todd-Brown K, Thomas L., Ferreira MA, Bender D, Maller J, Sklar P., de Bakker PI, Daly MJ, Sham PC: PLINK: Atool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575, 2007 (Pubitemid 47330214)
61. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald G.J., Waliszewska A., Kessing BD, Malasky MJ, Scafe C, Le E., De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale J.L., Moore JH, Poku K, Phair JP, Goedert J.J., Vlahov D., Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, Woodage T, Sninsky JJ, Hafler DA, Altshuler D, Gilbert DA, O'Brien SJ, Reich D: A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet 74: 1001-1013, 2004 (Pubitemid 38568970)
62. Halder I, Shriver M, Thomas M., Fernandez JR, Frudakis T: A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: Utility and applications. Hum Mutat 29: 648-658, 2008 (Pubitemid 351614589)